Daymark Wealth Partners’s HUMANIGEN, INC. HGEN Stock Holding History

Daymark Wealth Partners’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12,500	Closed	-$161	–	413
2023 Q3	$161	Hold	12,500	–	–	﹤0.01%	380
2023 Q2	$1.91K	Buy	+12,500	New	+$1.94K	﹤0.01%	375

Other funds holding HGEN

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

Daymark Wealth Partners's HGEN Position: Q4 2023 in Review

Daymark Wealth Partners sold out of HUMANIGEN, INC. (HGEN) in Q4 2023, closing a stake of 12,500 shares — an estimated $161 sold.

Daymark Wealth Partners first reported a position in HGEN in Q2 2023 and held it in 2 quarters. The position peaked at $1.91K in Q2 2023. 1 fund tracked by Wall St. Rank holds HGEN as of Q4 2023.

Daymark Wealth Partners reported no remaining HUMANIGEN, INC. position as of Q4 2023 after selling out during the quarter.
Daymark Wealth Partners sold 12,500 HUMANIGEN, INC. shares in Q4 2023, an estimated $161.
Daymark Wealth Partners first reported a position in HUMANIGEN, INC. in Q2 2023 and held it in 2 quarters.
Daymark Wealth Partners's HUMANIGEN, INC. position peaked at $1.91K in Q2 2023.
1 fund tracked by Wall St. Rank held HUMANIGEN, INC. as of Q4 2023.

Based on Daymark Wealth Partners's 13F filing for Q4 2023, filed 9 Jan 2024.